
Millions of people struggle with their mental health but can't access human support. The waiting lists are long, the costs are high, and the stigma is real. Every human deserves access to help whenβ¦

Millions of people struggle with their mental health but can't access human support. The waiting lists are long, the costs are high, and the stigma is real. Every human deserves access to help whenβ¦
What they do: AI-powered conversational companion for emotional support (speech and text) via mobile app
Headquarters: Brooklyn, New York
Founders: Chris Aeberli; Dustin Klebe; Lukas Wolf
Employee count: 23
Reported funding: $3.35M (seed / early-stage)
Mental health access and scalable emotional support
Healthtech / Mental health
$3.35M (reported total backing)
Reported investors include Y Combinator, Moonfire, Rebel Fund and SBXi; company cites participation in Y Combinator.
βBacked by notable early-stage investors including Y Combinator, Moonfire, Rebel Fund and SBXiβ
| Company |
|---|
About Sonia One in five adults struggles with their mental health each year and many will never see a therapist. Costs are high, waitlists are long, and stigma is still a real barrier for people to not seek help. Suicide is one of the leading causes of death for young people. Therapy works, but it doesn't scale.
We're building safe AI for mental health support that's clinically as effective as the best human therapists β accessible to everyone, at a fraction of the cost, and available anytime. We've recently had a major breakthrough. In our clinical research, we're now seeing significant improvements in anxiety and depression symptoms after just 2 weeks of use. And we receive daily messages about how Sonia is changing lives.
We're a 6-person team in San Francisco, backed by Y Combinator, Moonfire, and founders of Verkada, Reddit, and Instacart.
The Role
Sonia is an AI-native product β and our clinical research is what makes it trustworthy. We've already run clinical trials showing significant symptom reduction in anxiety and depression, and we're just getting started. We need someone to own and lead our entire research program: designing and running clinical trials, driving our FDA regulatory strategy, conducting safety research, publishing in peer-reviewed journals, and building the evidence base that establishes Sonia as a clinically validated treatment. You'll also co-write grant applications with our academic collaborators to secure research funding from federal and foundation sources.
This is a high-ownership role. You'll set the research vision for Sonia by shaping what we study, how we study it, and how we communicate our findings to regulators, clinicians, and the public. You'll work directly with the founders β who are deeply involved in AI research β and collaborate with leading academic research partners in the US and Europe.
Problems you'll work on
What the work looks like
Culture
We're kind to each other, we work hard, and we are thoughtful about what we're building. We're deeply mission-driven β we believe everyone deserves access to effective mental health support, and that belief shapes everything we do.
We're an AI-native team that believes a small, focused group can achieve what previously required 100 people. Everyone here has high ownership and real impact on the direction of the company. At the same time, we take clinical evidence and safety extremely seriously β moving fast never means cutting corners on rigor.
Our core team works 6 days a week together in our office in downtown SF. This role can be remote or hybrid, but we value regular in-person collaboration and prefer in person work.
Who We're Looking For
A few user stories from the past weeks
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week
Designing and leading clinical trials (RCTs, safety studies, longitudinal outcomes research) that demonstrate Sonia's efficacy and safety
Driving our FDA regulatory strategy:
Building the evidence package for regulatory submissions
Navigating pathways like De Novo or 510(k)
Staying ahead of the evolving regulatory landscape for AI-based therapies
Developing and maintaining safety monitoring frameworks for an AI therapy product used by real patients
Building and managing relationships with academic research collaborators and IRBs
Publishing research in peer-reviewed journals and presenting at clinical conferences
Securing research funding through grant applications, supported by experienced advisors and world-class academic partnerships
Defining outcome measures and clinical endpoints that capture meaningful therapeutic change